Peer Review History

Original SubmissionJanuary 17, 2022
Decision Letter - Minou Nowrousian, Editor

PONE-D-22-01622Analysis of secondary metabolite gene clusters and chitin biosynthesis pathways of Monascus purpureus with high production of pigment and citrinin based on whole-genome sequencingPLOS ONE

Dear Dr. Liu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Two experts in the field have reviewed your manuscript, you can find their comments below and in a separate pdf file. They make valuable suggestions to improve the manuscript. Please revise your manuscript carefully according to the reviewers' suggestions, except for the question of annotation where reviewer 1 suggests using MAKER instead of an Augustus/SNAP-based pipepline. Changing the annotation pipeline might be something to keep in mind for future studies. Please also make sure that all your data including the raw sequence reads have been submitted to the appropriate databases. The BioProject entry for your project suggests that you have submitte the assembly, but perhaps not yet the raw sequence reads (they could be submitted, for example, to the NCBI SRA database).

Please submit your revised manuscript by Apr 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Minou Nowrousian

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

e would also like to thank Editage for English language editing. This work was supported by the National Natural Science Foundation of China (No. 32101906), Natural Science Foundation of Hunan Province (No. 2021JJ31146); Open Project Program of the Hunan Provincial Key Laboratory of Food Safety Monitoring and Early Waring (No. 2021KFJJ02), Education Department of Scientific Research Project of Hunan Province (No. 20B619) and Education Department of Postgraduate Research and Innovation Project of Hunan Province(No. CX20210863, CX20210898)

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

This work was supported by the National Natural Science Foundation of China (No. 32101906), Natural Science Foundation of Hunan Province (No. 2021JJ31146); Open Project Program of the Hunan Provincial Key Laboratory of Food Safety Monitoring and Early Waring (No. 2021KFJJ02), Education Department of Scientific Research Project of Hunan Province (No. 20B619) and Education Department of Postgraduate Research and Innovation Project of Hunan Province(No. CX20210863, CX20210898)

Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

e would also like to thank Editage for English language editing. This work was supported by the National Natural Science Foundation of China (No. 32101906), Natural Science Foundation of Hunan Province (No. 2021JJ31146); Open Project Program of the Hunan Provincial Key Laboratory of Food Safety Monitoring and Early Waring (No. 2021KFJJ02), Education Department of Scientific Research Project of Hunan Province (No. 20B619) and Education Department of Postgraduate Research and Innovation Project of Hunan Province(No. CX20210863, CX20210898)

Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The Monascus purpureus csu-m183 strain is of industrial importance and warrants a detailed genomic analysis. The authors here have done a good job describing its genomic contents, particularly in relation to pigment and citrinin metabolism. I have a couple of comments.

1. Annotation pipelines such as MAKER pipeline take into account various evidences to predict the genes in a genome. It might perform better than solely using augustus and SNAP.

2. In methods section, the genome assembly process is not described in enough details that it can be reproduced. Parameters used in HGAP program are missing.

3. In introduction, it is not clearly rationalized why the genome sequencing of this particular strain is necessary while several other high pigment producing strains are already sequenced.

4. With several M. purpureus genomes available, it might be helpful to conduct a comparative genomic analysis among them to elucidate likely mechanism that CSU-m183 strain is special in its metabolic capacity.

Reviewer #2: 1. 1. Is the manuscript technically sound, and do the data support the conclusions?

Ans: Concerns described in the attached document.

2. Has the statistical analysis been performed appropriately and rigorously?

Ans: I didnot find a section in the manuscript about the statistical analysis they used, specifically for the qPCR data.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: Review_PlosOne_20220219.pdf
Revision 1

ID: PONE-D-22-01622

Title: Analysis of secondary metabolite gene clusters and chitin biosynthesis pathways of Monascus purpureus with high production of pigment and citrinin based on whole-genome sequencing

Journal: Plos One

Dear Editor,

Thank you very much for your and reviewers' comments concerning our manuscript entitled “Analysis of secondary metabolite gene clusters and chitin biosynthesis pathways of Monascus purpureus with high production of pigment and citrinin based on whole-genome sequencing(PONE-D-22-01622)”. We have studied the editor/reviewer comments and made corrections that we hope meet with your approval. The main corrections have been marked in red in the revised manuscript (PONE-D-22-01622) and our details responses to the comments are given below in bold type.

Editor' comments:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response:Thank you very much for your comment, we have changed the manuscript to comply with PLOS ONE's style requirements, including file naming requirements

2. Thank you for stating the following financial disclosure:

we would also like to thank Editage for English language editing. This work was supported by the National Natural Science Foundation of China (No. 32101906), Natural Science Foundation of Hunan Province (No. 2021JJ31146); Open Project Program of the Hunan Provincial Key Laboratory of Food Safety Monitoring and Early Waring (No. 2021KFJJ02), Education Department of Scientific Research Project of Hunan Province (No. 20B619) and Education Department of Postgraduate Research and Innovation Project of Hunan Province(No. CX20210863, CX20210898)

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Response:Thank you for your comment. Funders JL and SZ designed the study and annotated the genome, respectively. SZ and JL co-write the manuscript. All authors read and approved the final version of the manuscript.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

we would also like to thank Editage for English language editing. This work was supported by the National Natural Science Foundation of China (No. 32101906), Natural Science Foundation of Hunan Province (No. 2021JJ31146); Open Project Program of the Hunan Provincial Key Laboratory of Food Safety Monitoring and Early Waring (No. 2021KFJJ02), Education Department of Scientific Research Project of Hunan Province (No. 20B619) and Education Department of Postgraduate Research and Innovation Project of Hunan Province(No. CX20210863, CX20210898)

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response:Thank you for your comment, we have deleted the funding information in the manuscript and submitted them in the Funding Statement.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Response:Thank you for your comment, we have provided accession numbers for the relevant data in the Materials and Methods of the manuscript (page 9, line 9-13).

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Response:Thank you for your comment, we have moved the ethics statement to the Materials and Methods section of the manuscript (page 9, line 14-16).

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response:Thank you for your comment, we have changed the supplemental information as requested (page 31, line 20-21).

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response:Thank you for your comment, we have checked the reference list to make sure it is complete and correct.

Reviewers' comments:

Reviewer #1:

The Monascus purpureus CSU-M183 strain is of industrial importance and warrants a detailed genomic analysis. The authors here have done a good job describing its genomic contents, particularly in relation to pigment and citrinin metabolism. I have a couple of comments.

1. Annotation pipelines such as MAKER pipeline take into account various evidences to predict the genes in a genome. It might perform better than solely using augustus and SNAP.

Response:Thank you very much for your comment.

2. In methods section, the genome assembly process is not described in enough details that it can be reproduced. Parameters used in HGAP program are missing.

Response:Thank you very much for your comment, we have re-described the genome assembly process in detail in the Materials and methods section of WGS and assembling (page 7, line 4-7).

3. In introduction, it is not clearly rationalized why the genome sequencing of this particular strain is necessary while several other high pigment producing strains are already sequenced.

Response:Thank you very much for your comment. There are not many published whole genome sequences of Monascus so far, and there are certain differences between the Monascus species, such as some do not contain a complete monacolin K biosynthetic gene cluster, and some do not produce citrinin, etc. Besides, we illustrate that the cell wall is an ideal target for the regulation of fungal morphology, chitin is the main component of cell wall, but the number of genes encoding chitin synthase and chitin biosynthesis pathway in M. purpureus is still unclear (page 5, line 3-11). Therefore, we comprehensively predicted the gene encoding chitin synthase and the biosynthetic pathway of chitin in M. purpureus CSU-M183 through whole genome sequencing for future morphological studies.

4.With several M. purpureus genomes available, it might be helpful to conduct a comparative genomic analysis among them to elucidate likely mechanism that CSU-M183 strain is special in its metabolic capacity.

Response:Thank you very much for your suggestion. Based on the whole genome sequence of strain CSU-M183, we have performed genome resequencing of the mutant strains (morphologically different strain), focusing on the genes related to morphology, metabolism and growth, and to explore the relationship between the morphology, growth and metabolism of Monascus, for our future study.

Reviewer #2:

In this study, the authors employed a hybrid sequencing strategy (PacBio and Illumina) to get the whole-genome assembly of a Monascus purpureus mutant. The authors comprehensively addressed the predicted secondary metabolite biosynthetic clusters as well as the expression of chitin and Monascus pigments genes in mutant strain, Monascus purpureus CSU-M183. Although there are some concerns (given below), I find this study relevant for the research community.

Comments:

1. In the Materials and methods section of WGS and assembling, the information about the method of PaBioRS II library preparation is not described. The authors should add information about the PacBio sequencing library construction and parameters used for filtering the reads. The authors should also provide information on the Illumina NGS sequencing platform used, and the processing of Illumina reads.

Response:Thank you very much for you comment, we have added relavant information in the Materials and methods section of WGS and assembling (page 7 line 8 to page 8 line 6).

2. They used two sequencing platforms to generate the assembly of Monascus purpureus mutant. However, they did not describe how they validated the completeness of the genome assembly.

Response:Thank you very much for you comment. Indeed the genome assembly was performed using HGAP2 for PacBio RSII reads, and Illumina reads were mapped on assembled genome to correct possible SNPs and Indels. Though we finally obtained a high-quality genome with 69 contigs, it’s not assembled into chromosome level. So we did not estimate the completeness of the genome (page 7 line 8 to page 8 line 6).

3. I am confused about the description of how they obtained the M. purpureus mutant strain. If they created the mutant strain from parent M. purpureus LQ-6, the authors have to describe the mutagenesis and screening. Otherwise, they have to cite the previous study that reported the M. purpureus CSU-M183 mutant.

Response:Thank you very much for you comment, we have cited our previous research of the M. purpureus CSU-M183 mutant(page 6, line 2).

4. Fig. 1 – I recommend giving the alphabets corresponding to each annotated function inside the pie chart. I find the pie chart shown in the manuscript not helpful because some colors are same for annotated functions. For example, the color for E, O, and Z are the same. The other option is providing the percentage of predicted genes with annotated function as a table instead of a pie chart.

Response:Thank you very much for you comment, the percentage of predicted genes with annotation functions have been presented in a table (Table 2).

5. In the methods section of RT-qPCR, the authors should add the statistical methods used for qPCR analysis. They did not mention how many replicates they used for qPCR experiments. Response:Thank you very much for you comment. We have supplemented Statistical analysis in the Materials and Methods to illustrate the statistical methods used in this study and the number of experimental replicates (page 9, line 17-22).

6. In the RT-qPCR results, the authors should give the p-values of significantly higher qPCR expression results instead of using terminologies such as “obviously higher”, “relatively significant”, “very significant,” or “extremely significant”. I find it hard to follow what the authors meant by “extremely significant” and “very significant”. They should also describe in the legend of Figure 4 on what each type of asterisks (**, ***) meant.

Response:Thank you very much for your comment, we gave the p-values of significantly higher qPCR expression results and supplemented in the legend of Fig 3 on what each type of asterisks meant (page 22, line 12-13).

7. Page #14 (Line #18) - Page # 15 (Line #3) – “As shown in Fig. 4, phosphoacetylglucosamine mutase (PGM3) [EC:5.4.2.3] (encoded by gene g4907) converts N-acetyl-D-glucosamine 6-phosphate (GlcNAc-6P) to N-acetyl-alpha-D glucosamine 1-phosphate (GlcNAc-1P), which is then dephosphorylated by UDP-N22 acetylglucosamine diphosphorylase (UAP1) [EC:2.7.7.23] (encoded by gene g6630) to yield UDP-N-acetyl-D-glucosamine (UDP-GlcNAc)”. The above description matches Fig 5, not Fig 4.

Response:Thank you very much for your comment,we have corrected it.

8. This manuscript requires language editing before accepting for publication. I have noticed the repetition of words, spelling, and grammatical errors. Although some paragraphs are fairly well written, I recommend revising the manuscript with the assistance of a native English speaker. Response:Thank you for your comment, the manuscript has been revised with the help of native English speakers.

9. Authors should correct the format of in-text citation throughout the manuscript. Also, keep consistency in the units' format (Ex: ml or mL)

Response:Thank you very much for your comment, we have changed the in-text citation format as requested and unified the unit of volume to ml.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Minou Nowrousian, Editor

PONE-D-22-01622R1Analysis of secondary metabolite gene clusters and chitin biosynthesis pathways of Monascus purpureus with high production of pigment and citrinin based on whole-genome sequencingPLOS ONE

Dear Dr. Liu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The revised manuscript is improved with respect to many aspects that were pointed out by the reviewers, but some aspects still need improvement. Please carefully address the following points: 1. Please submit the PacBio sequencing reads (raw data) and Illumina data you generated to an appropriate database (e.g. NCBI SRA) and give the SRA accession number. Currently, it appears as if you only submitted the assembled genome, but not the raw sequence data, which are also important. 2. Some sections of the manuscript were apparently changed in an attempt to improve the English, but this is not actually better in many cases. Especially the abstract now contains a number of language problems in the changes sentences that were not present before. Please carefully check the manuscript and correct language problems. 3. Reviewer 2 suggested checking for genome completeness, which is something that can and should be done especially with genomes that are not assembled fully at chromosome level. You can use the presence of conserved genes to check for completeness (of the gene space at least), e.g. by using the BUSCO tool or other methods to check for the presence of expected conserved eukaryotic genes. Please do this and document the method used and the results in your manuscript. 4. Reviewer 1 asked about the reasons why this particular Monascus purpureus strain was sequenced. This is still not sufficiently explained in the introduction. Please explain what makes this strain interesting (not the species as such, but this particular strain).

Please submit your revised manuscript by May 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Minou Nowrousian

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Editor' comments:

1. Please submit the PacBio sequencing reads (raw data) and Illumina data you generated to an appropriate database (e.g. NCBI SRA) and give the SRA accession number. Currently, it appears as if you only submitted the assembled genome, but not the raw sequence data, which are also important.

Response:Thank you very much for your comment. Firstly, due to the COVID-19 in Shanghai, the people were strongly asked to work at home, and the raw date is being stored on the server of sequencing company (Chinese National Human Genome Center at Shanghai). Secondly, we would submit the raw date to NCBI-SRA as soon as possible when the staff return to work. Thus, we just provided the raw date of SRA acceptance number with BioProject of PRJNA824977 in this revised manuscript (PONE-D-22-01622R2;Page 9,Line 14-15).

2. Some sections of the manuscript were apparently changed in an attempt to improve the English, but this is not actually better in many cases. Especially the abstract now contains a number of language problems in the changes sentences that were not present before. Please carefully check the manuscript and correct language problems.

Response:Thank you for your comment, the manuscript has been revised and marked in blue.

Reviewers' comments:

Reviewer #1:

1. Reviewer 1 asked about the reasons why this particular Monascus purpureus strain was sequenced. This is still not sufficiently explained in the introduction. Please explain what makes this strain interesting (not the species as such, but this particular strain).

Response:Thank you very much for your comment. We have explained what makes this strain interesting in the introduction(Page 5, Line 6-16).

Reviewer #2:

Reviewer 2 suggested checking for genome completeness, which is something that can and should be done especially with genomes that are not assembled fully at chromosome level. You can use the presence of conserved genes to check for completeness (of the gene space at least), e.g. by using the BUSCO tool or other methods to check for the presence of expected conserved eukaryotic genes. Please do this and document the method used and the results in your manuscript.

Comments:

Response:Thank you very much for you comment. We have checked the completeness of the genome by using the BUSCO tool. The corresponding methods(Page 6, Line 20-22) and results(Page 10, Line 9-13)have been supplemented in the Manuscript.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Minou Nowrousian, Editor

Analysis of secondary metabolite gene clusters and chitin biosynthesis pathways of Monascus purpureus with high production of pigment and citrinin based on whole-genome sequencing

PONE-D-22-01622R2

Dear Dr. Liu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Minou Nowrousian

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Minou Nowrousian, Editor

PONE-D-22-01622R2

Analysis of secondary metabolite gene clusters and chitin biosynthesis pathways of Monascus purpureus with high production of pigment and citrinin based on whole-genome sequencing

Dear Dr. Liu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Minou Nowrousian

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .